Assertio Holdings, Inc. (23)

Browse by Contract Category

Contracts

Indenture, dated as of August 25, 2022, between Assertio Holdings, Inc. and U.S. Bank Trust Company, National Association, as trustee (Filed With SEC on August 25, 2022)
Separation Agreement and Release of Claims between Mark Strobeck and Assertio Management, LLC, dated December 14, 2020 (incorporated by reference to Exhibit 10.15 to the Companys... (Filed With SEC on March 10, 2022)
Form of Management Continuity Agreement (Filed With SEC on March 10, 2022)
Amendment No. 3 to Collaborative License, Exclusive Manufacture and Global Supply Agreement between Zyla Life Sciences and Cosette Pharmaceuticals, Inc. effective July 9, 2021 (Filed With SEC on November 4, 2021)
Offer Letter, dated June 23, 2020, between Zyla Life Sciences and Megan C. Timmins (Filed With SEC on August 10, 2020)
Separation Agreement and Release of Claims between Todd N. Smith and Assertio Management, LLC, dated December 14, 2020 (incorporated by reference to Exhibit 10.14 to the Companys... (Filed With SEC on March 10, 2022)
Amended and Restated Annual Bonus Plan (Filed With SEC on March 10, 2022)
Second Supplemental Indenture, dated as of December 15, 2021, by and among Otter Pharmaceuticals, LLC, the Company, the existing guarantors and Wilmington Savings Fund Society (Filed With SEC on March 10, 2022)
Asset Purchase Agreement, dated as of December 15, 2021, by and among Otter Pharmaceuticals, LLC, Antares Pharma, Inc. and the Company (Filed With SEC on March 10, 2022)
Sales Agreement, dated as of December 17, 2021, by and between the Company and Roth Capital Partners, LLC (Filed With SEC on March 10, 2022)
Separation Agreement and Release of Claims between Todd N. Smith and Assertio Management, LLC, dated December 14, 2020 (Filed With SEC on March 12, 2021)
Separation Agreement and Release of Claims between Mark Strobeck and Assertio Management, LLC, dated December 14, 2020 (Filed With SEC on March 12, 2021)
Placement Agency Agreement by and between the Company and Roth Capital Partners, LLC, dated as of February 10, 2021 (Filed With SEC on February 12, 2021)
Securities Purchase Agreement by and among the Company and certain investors, dated as of February 10, 2021 (Filed With SEC on February 12, 2021)
Placement Agency Agreement by and between the Company and Roth Capital Partners, LLC, dated as of February 5, 2021 (Filed With SEC on February 9, 2021)
Securities Purchase Agreement by and among the Company and certain investors, dated as of February 5, 2021 (Filed With SEC on February 9, 2021)
Registration Rights Agreement between the Company and Loan Security Holdings I LLC, dated May 20, 2020 (Filed With SEC on August 10, 2020)
Transition and Consulting Agreement, dated June (Filed With SEC on August 10, 2020)
Form of Management Continuity Agreement, dated June 23, 2020, between Zyla Life Sciences and Zyla Life Sciences executive officers (Filed With SEC on August 10, 2020)
Offer Letter, dated June 23, 2020, between Zyla Life Sciences and Mark Strobeck, Ph.D (Filed With SEC on August 10, 2020)
Employment Agreement between Zyla Life Sciences and Todd N. Smith, dated June 17, 2020 (Filed With SEC on August 10, 2020)
Form of Warrant (Filed With SEC on August 10, 2020)
Supplemental Indenture by and among Assertio Holdings and Wilmington Savings Fund Society dated as of May 20, 2020 (Filed With SEC on May 27, 2020)